Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ret Proto-Oncogene Protein (RET) (AA 658-1114) (His-GST)

Dieses Recombinant Ret Proto-Oncogene-Protein wird in Baculovirus infected Insect Cells produziert.
Produktnummer ABIN7317056
746,00 €
Zzgl. Versandkosten 20,00 € und MwSt
50 μg
Lieferung nach: Deutschland
Lieferung in 9 bis 13 Werktagen

Kurzübersicht für Ret Proto-Oncogene Protein (RET) (AA 658-1114) (His-GST) (ABIN7317056)

Target

Alle Ret Proto-Oncogene (RET) Proteine anzeigen
Ret Proto-Oncogene (RET)

Protein-Typ

Recombinant

Biologische Aktivität

Active

Spezies

  • 40
  • 4
Human

Quelle

  • 29
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Baculovirus infected Insect Cells

Reinheit

> 90 % as determined by reducing SDS-PAGE.
  • Proteineigenschaft

    AA 658-1114

    Aufreinigungstag / Konjugat

    Dieses Ret Proto-Oncogene Protein ist gelabelt mit His-GST.

    Verwendungszweck

    Recombinant Human RET Kinase Protein (aa 658-1114, His & GST Tag)

    Sequenz

    His 658-Ser 1114

    Produktmerkmale

    A DNA sequence encoding the cytoplasmic domain of human RET (P07949-1) (His 658-Ser 1114) was fused with the N-terminal polyhistidine-tagged GST tag at the N-terminus.

    Sterilität

    0.2 μm filtered

    Endotoxin-Niveau

    < 1.0 EU per μg of the protein as determined by the LAL method.

    Biological Activity Comment

    The specific activity was determined to be 17 nmol/min/mg using synthetic TRK-C-derived Peptide (R11-VYSTDYYRLFNPS) as substrate.
  • Möchten Sie weitere Optionen für dieses Protein ?

    !
    Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!

    Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen

  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Supplied as sterile solution of 20 mM Tris, 500 mM NaCl, 10 % glycerol, pH 8.0

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.

    Haltbarkeit

    6 months
  • Target

    Ret Proto-Oncogene (RET)

    Andere Bezeichnung

    RET Kinase

    Hintergrund

    CDHF12,CDHR16,HSCR1,MEN2A,MEN2B,MTC1,PTC,RET-ELE1,RET51,RET proto-oncogene, also known as RET, is a cell-surface molecule that transduce signals for cell growth and differentiation. It contains 1 cadherin domain and 1 protein kinase domain. RET proto-oncogene belongs to the protein kinase superfamily, tyr protein kinase family. RET proto-oncogene is involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. It phosphorylates PTK2/FAK1 and regulates both cell death/survival balance and positional information. RET is required for the molecular mechanisms orchestration during intestine organogenesis, involved in the development of enteric nervous system and renal organogenesis during embryonic life, promotes the formation of Peyer's patch-like structures, modulates cell adhesion via its cleavage, involved in the development of the neural crest. RET proto-oncogene is active in the absence of ligand, triggering apoptosis. RET acts as a dependence receptor, in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. It also regulates nociceptor survival and size, triggers the differentiation of rapidly adapting (RA) mechanoreceptors, mediated several diseases such as neuroendocrine cancers.

    Molekulargewicht

    Calculated MW: 76.7 kDa

    Observed MW: 70 kDa

    Gen-ID

    5979

    UniProt

    P07949

    Pathways

    RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Sie sind hier:
Chat with us!